| |
| |
|
| Insider
Information: |
Ende Eric J |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
311,992 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,710,182 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
311,992 |
|
|
| Total
Value |
$2,710,182 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
8
|
0
|
|
Stock
price went up :
|
7
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
7.0
|
0.0
|
| Percentage
Gain/Loss : |
 116.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Genzyme Corp |
GENZ |
Director |
2011-04-04 |
0 |
2011-04-04 |
0 |
Premium* |
|
|
Matinas Biopharma Holdings, Inc. |
MTNB |
Director |
2021-06-19 |
144,092 |
2018-03-30 |
0 |
Premium* |
|
|
AVADEL Pharmaceuticals Plc |
AVDL |
Director |
2023-05-18 |
167,900 |
2019-01-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2023-05-18 |
4 |
B |
$13.93 |
$181,100 |
D/D |
13,000 |
167,900 |
2.39 |
% |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2022-11-22 |
4 |
B |
$7.80 |
$156,050 |
D/D |
20,000 |
154,900 |
2.39 |
% |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2022-06-01 |
4 |
B |
$2.27 |
$45,496 |
D/D |
20,000 |
134,900 |
2.39 |
% |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2022-05-31 |
4 |
B |
$2.16 |
$32,394 |
D/D |
15,000 |
114,900 |
2.39 |
% |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2022-05-27 |
4 |
B |
$2.45 |
$36,747 |
D/D |
15,000 |
99,900 |
2.39 |
% |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2021-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
4,800 |
120,092 |
0 |
- |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2021-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
144,092 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2020-09-17 |
4 |
B |
$5.79 |
$98,376 |
D/D |
17,000 |
84,900 |
2.39 |
% |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2020-08-13 |
4 |
B |
$7.74 |
$38,928 |
D/D |
5,000 |
67,900 |
2.39 |
% |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2020-08-12 |
4 |
B |
$7.76 |
$116,355 |
D/D |
15,000 |
62,900 |
2.39 |
% |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2020-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
3,600 |
115,292 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2019-12-04 |
4 |
B |
$5.97 |
$59,700 |
D/D |
10,000 |
47,900 |
2.39 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2019-11-15 |
4 |
B |
$4.98 |
$49,762 |
D/D |
10,000 |
37,900 |
2.39 |
- |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2019-08-20 |
4 |
B |
$0.66 |
$13,200 |
D/D |
20,000 |
109,292 |
2.39 |
- |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2019-08-19 |
4 |
B |
$0.68 |
$13,650 |
D/D |
20,000 |
89,292 |
2.39 |
- |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2019-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
2,400 |
111,692 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2019-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
27,900 |
27,900 |
0 |
- |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2018-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
15,022 |
57,091 |
0 |
- |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2018-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
9,715 |
42,069 |
0 |
- |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2018-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
20,594 |
32,354 |
0 |
- |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2018-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
11,760 |
11,760 |
0 |
- |
|
| MTNB |
Matinas Biopharma Holding... |
Director |
– • – |
2017-04-03 |
4/A |
A |
$0.00 |
$0 |
D/D |
12,201 |
12,201 |
0 |
- |
|
| GENZ |
Genzyme Corp |
Director |
– • – |
2011-04-04 |
4 |
D |
$74.00 |
$175,750 |
D/D |
(2,375) |
0 |
0 |
- |
|
| GENZ |
Genzyme Corp |
Director |
– • – |
2011-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,375 |
2,375 |
0 |
- |
|
24 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
